“…Various genes such as PDK4 [140], ALB (albumin) [141], EGR1 [142], RYR3 [48], CYP27B1 [143], GATA6 [144], NR4A3 [145], TET2 [146], CACNA1D [147], KLF15 [148], CYP4A11 [149], ATOH8 [150], ATF3 [151], EGF (epidermal growth factor) [152], LPL (lipoprotein lipase) [153], PPARGC1A [154], PLG (plasminogen) [155], USP2 [156], PDE4D [157], RGS2 [158], ILK (integrin linked kinase) [159], SLC26A4 [160], PER1 [161], LGR4 [72], GABRB3 [162], TRPC1 [163], KL (klotho) [164], NOX4 [165], S100A12 [166], NEDD9 [167], ANKRD36 [168], IRF9 [169], GIMAP5 [170], ND2 [171], CHGA (chromogranin A) [172], DBH (dopamine beta-hydroxylase) [173], LTA (lymphotoxin alpha) [174], MPO (myeloperoxidase) [175], CD70 [176], LCN2 [177], TLR6 [178], TREM2 [179], NLRP12 [180], CCR5 [181], IL1RN [182], CX3CR1 [183], TRPM2 [184], TNF (tumor necrosis factor) [185], TLR7 [186], NOD2 [187], TNFRSF1B [188], CCR2 [181], CCL5 [189], PLA2G7 [190], TH (tyrosine hydroxylase) [191], WNT7A [192], ADRB3 [193], IL10RA [194], NOS3 [195], PIK3R5 [196], APLNR (apelin receptor) [197], COMP (cartilage oligomeric matrix protein) [198], RETN (resistin) [199], S100B [200], IGFBP1 [201] and COL1A1 [202] are crucial in the progression of hypertension. Evidence suggests that PDK4 [203], ALB (albumin) [204], EGR1 [205], RYR3 [206], DUSP1 [207], EYA4 [208], CYP27B1 [143<...…”